PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy

Gastrointestinal (GI) malignancies are the most prevalent tumors worldwide, with increasing incidence and mortality. Although surgical resection, chemotherapy, radiotherapy, and molecular targeted therapy have led to significant advances in the treatment of GI cancer patients, overall survival is st...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Junyu, Lin, Jianzhen, Wang, Anqiang, Wu, Liangcai, Zheng, Yongchang, Yang, Xiaobo, Wan, Xueshuai, Xu, Haifeng, Chen, Shuguang, Zhao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543600/
https://www.ncbi.nlm.nih.gov/pubmed/28774337
http://dx.doi.org/10.1186/s13045-017-0511-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543600/
https://www.ncbi.nlm.nih.gov/pubmed/28774337
http://dx.doi.org/10.1186/s13045-017-0511-2

Ejemplares similares